Differential regulation of osteoadherin (OSAD) by TGF-β1 and BMP-2

Biochemical and Biophysical Research Communications

Volumn 349, Issue 3, 2006, Pages 1057-1064

  Rehn, Anders P ^a   Chalk, Alistair M ^a   Wendel, Mikael ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

BMP 2; Osteoadherin; Osteoblast; Promoter; TGF 1; Transcription factor binding site

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; OSTEOADHERIN; PROTEOGLYCAN; SMAD3 PROTEIN; SMAD4 PROTEIN; TRANSCRIPTION FACTOR AP 1; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; COMPUTER MODEL; CONTROLLED STUDY; DOWN REGULATION; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SENSITIVITY ANALYSIS; UPREGULATION;

ANIMALS; BASE SEQUENCE; BINDING SITES; BONE MORPHOGENETIC PROTEINS; CELLS, CULTURED; COMPUTATIONAL BIOLOGY; EXTRACELLULAR MATRIX PROTEINS; GENE EXPRESSION REGULATION; GENES, REPORTER; HUMANS; MICE; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); PROTEOGLYCANS; RNA, MESSENGER; SEQUENCE HOMOLOGY, AMINO ACID; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 33748603189     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.08.133     Document Type: Article

References (51)

1. Hocking A.M., Shinomura T., and McQuillan D.J. Leucine-rich repeat glycoproteins of the extracellular matrix. Matrix Biol. 17 (1998) 1-19
2. Wendel M., Sommarin Y., and Heinegard D. Bone matrix proteins: isolation and characterization of a novel cell-binding keratan sulfate proteoglycan (osteoadherin) from bovine bone. J. Cell Biol. 141 (1998) 839-847
3. Sommarin Y., Wendel M., Shen Z., Hellman U., and Heinegard D. Osteoadherin, a cell-binding keratan sulfate proteoglycan in bone, belongs to the family of leucine-rich repeat proteins of the extracellular matrix. J. Biol. Chem. 273 (1998) 16723-16729
4. Shen Z., Gantcheva S., Sommarin Y., and Heinegard D. Tissue distribution of a novel cell binding protein, osteoadherin, in the rat. Matrix Biol. 18 (1999) 533-542
5. Buchaille R., Couble M.L., Magloire H., and Bleicher F. Expression of the small leucine-rich proteoglycan osteoadherin/osteomodulin in human dental pulp and developing rat teeth. Bone 27 (2000) 265-270
6. Janssens K., ten Dijke P., Janssens S., and Van Hul W. Transforming growth factor-beta1 to the bone. Endocr. Rev. 26 (2005) 743-774
7. Provot S., and Schipani E. Molecular mechanisms of endochondral bone development. Biochem. Biophys. Res. Commun. 328 (2005) 658-665
8. Hughes F.J., Turner W., Belibasakis G., and Martuscelli G. Effects of growth factors and cytokines on osteoblast differentiation. Periodontology 2000 41 (2006) 48-72
9. Pfeilschifter J., Bonewald L., and Mundy G.R. Characterization of the latent transforming growth factor beta complex in bone. J. Bone Miner Res. 5 (1990) 49-58
10. Wozney J.M. Bone morphogenetic proteins. Prog. Growth Factor Res. 1 (1989) 267-280
11. Yamaguchi A. Regulation of differentiation pathway of skeletal mesenchymal cells in cell lines by transforming growth factor-beta superfamily. Semin. Cell Biol. 6 (1995) 165-173
12. Bae S.C., Lee K.S., Zhang Y.W., and Ito Y. Intimate relationship between TGF-beta/BMP signaling and runt domain transcription factor, PEBP2/CBF. J. Bone Joint Surg. Am. 83-A Suppl. 1 (2001) S48-S55
13. Balint E., Lapointe D., Drissi H., van der Meijden C., Young D.W., van Wijnen A.J., Stein J.L., Stein G.S., and Lian J.B. Phenotype discovery by gene expression profiling: mapping of biological processes linked to BMP-2-mediated osteoblast differentiation. J. Cell Biochem. 89 (2003) 401-426
14. Chen D., Zhao M., Harris S.E., and Mi Z. Signal transduction and biological functions of bone morphogenetic proteins. Front. Biosci. 9 (2004) 349-358
15. Matys V., Fricke E., Geffers R., Gossling E., Haubrock M., Hehl R., Hornischer K., Karas D., Kel A.E., Kel-Margoulis O.V., Kloos D.U., Land S., Lewicki-Potapov B., Michael H., Munch R., Reuter I., Rotert S., Saxel H., Scheer M., Thiele S., and Wingender E. TRANSFAC: transcriptional regulation, from patterns to profiles. Nucleic Acids Res. 31 (2003) 374-378
16. Kel A.E., Gossling E., Reuter I., Cheremushkin E., Kel-Margoulis O.V., and Wingender E. MATCH: a tool for searching transcription factor binding sites in DNA sequences. Nucleic Acids Res. 31 (2003) 3576-3579
17. Brudno M., Do C.B., Cooper G.M., Kim M.F., Davydov E., Green E.D., Sidow A., and Batzoglou S. LAGAN and Multi-LAGAN: efficient tools for large-scale multiple alignment of genomic DNA. Genome Res. 13 (2003) 721-731
18. Wasserman W.W., and Sandelin A. Applied bioinformatics for the identification of regulatory elements. Nat. Rev. Genet. 5 (2004) 276-287
19. Bellows C.G., Aubin J.E., Heersche J.N., and Antosz M.E. Mineralized bone nodules formed in vitro from enzymatically released rat calvaria cell populations. Calcif. Tissue Int. 38 (1986) 143-154
20. Lian J.B., Stein J.L., Stein G.S., van Wijnen A.J., Montecino M., Javed A., Gutierrez S., Shen J., Zaidi S.K., and Drissi H. Runx2/Cbfa1 functions: diverse regulation of gene transcription by chromatin remodeling and co-regulatory protein interactions. Connect. Tissue Res. 44 Suppl. 1 (2003) 141-148
21. Sottile V., Thomson A., and McWhir J. In vitro osteogenic differentiation of human ES cells. Cloning Stem Cells 5 (2003) 149-155
22. Ramstad V.E., Franzen A., Heinegard D., Wendel M., and Reinholt F.P. Ultrastructural distribution of osteoadherin in rat bone shows a pattern similar to that of bone sialoprotein. Calcif. Tissue Int. 72 (2003) 57-64
23. Rittling S.R., Matsumoto H.N., McKee M.D., Nanci A., An X.R., Novick K.E., Kowalski A.J., Noda M., and Denhardt D.T. Mice lacking osteopontin show normal development and bone structure but display altered osteoclast formation in vitro. J. Bone Miner. Res. 13 (1998) 1101-1111
24. Chellaiah M.A., Kizer N., Biswas R., Alvarez U., Strauss-Schoenberger J., Rifas L., Rittling S.R., Denhardt D.T., and Hruska K.A. Osteopontin deficiency produces osteoclast dysfunction due to reduced CD44 surface expression. Mol. Biol. Cell 14 (2003) 173-189
25. Ross F.P., Chappel J., Alvarez J.I., Sander D., Butler W.T., Farach-Carson M.C., Mintz K.A., Robey P.G., Teitelbaum S.L., and Cheresh D.A. Interactions between the bone matrix proteins osteopontin and bone sialoprotein and the osteoclast integrin alpha v beta 3 potentiate bone resorption. J. Biol. Chem. 268 (1993) 9901-9907
26. Fleischmajer R., Fisher L.W., MacDonald E.D., Jacobs Jr. L., Perlish J.S., and Termine J.D. Decorin interacts with fibrillar collagen of embryonic and adult human skin. J. Struct. Biol. 106 (1991) 82-90
27. Hedbom E., and Heinegard D. Binding of fibromodulin and decorin to separate sites on fibrillar collagens. J. Biol. Chem. 268 (1993) 27307-27312
28. Pringle G.A., and Dodd C.M. Immunoelectron microscopic localization of the core protein of decorin near the d and e bands of tendon collagen fibrils by use of monoclonal antibodies. J. Histochem. Cytochem. 38 (1990) 1405-1411
29. Rada J.A., McFarland A.L., Cornuet P.K., and Hassell J.R. Proteoglycan synthesis by scleral chondrocytes is modulated by a vision dependent mechanism. Curr. Eye Res. 11 (1992) 767-782
30. Scott J.E., and Orford C.R. Dermatan sulphate-rich proteoglycan associates with rat tail-tendon collagen at the d band in the gap region. Biochem. J. 197 (1981) 213-216
31. Sugars R.V., Milan A.M., Brown J.O., Waddington R.J., Hall R.C., and Embery G. Molecular interaction of recombinant decorin and biglycan with type I collagen influences crystal growth. Connect. Tissue Res. 44 Suppl. 1 (2003) 189-195
32. Xu T., Bianco P., Fisher L.W., Longenecker G., Smith E., Goldstein S., Bonadio J., Boskey A., Heegaard A.M., Sommer B., Satomura K., Dominguez P., Zhao C., Kulkarni A.B., Robey P.G., and Young M.F. Targeted disruption of the biglycan gene leads to an osteoporosis-like phenotype in mice. Nat. Genet. 20 (1998) 78-82
33. Tasheva E.S., Klocke B., and Conrad G.W. Analysis of transcriptional regulation of the small leucine rich proteoglycans. Mol. Vis. 10 (2004) 758-772
34. Marie P.J., Debiais F., and Hay E. Regulation of human cranial osteoblast phenotype by FGF-2, FGFR-2 and BMP-2 signaling. Histol. Histopathol. 17 (2002) 877-885
35. Elford P.R., Guenther H.L., Felix R., Cecchini M.G., and Fleisch H. Transforming growth factor-beta reduces the phenotypic expression of osteoblastic MC3T3-E1 cells in monolayer culture. Bone 8 (1987) 259-262
36. Noda M., and Rodan G.A. Type beta transforming growth factor regulates expression of genes encoding bone matrix proteins. Connect. Tissue Res. 21 (1989) 71-75
37. Aubin J.E. Regulation of osteoblast formation and function. Rev. Endocr. Metab. Disord. 2 (2001) 81-94
38. Bunyaratavej P., Hullinger T.G., and Somerman M.J. Bone morphogenetic proteins secreted by breast cancer cells upregulate bone sialoprotein expression in preosteoblast cells. Exp. Cell Res. 260 (2000) 324-333
39. Chen D., Harris M.A., Rossini G., Dunstan C.R., Dallas S.L., Feng J.Q., Mundy G.R., and Harris S.E. Bone morphogenetic protein 2 (BMP-2) enhances BMP-3, BMP-4, and bone cell differentiation marker gene expression during the induction of mineralized bone matrix formation in cultures of fetal rat calvarial osteoblasts. Calcif. Tissue Int. 60 (1997) 283-290
40. Takaoka K., Nakahara H., Yoshikawa H., Masuhara K., Tsuda T., and Ono K. Ectopic bone induction on and in porous hydroxyapatite combined with collagen and bone morphogenetic protein. Clin. Orthop. Relat. Res. (1988) 250-254
41. Alliston T., Choy L., Ducy P., Karsenty G., and Derynck R. TGF-beta-induced repression of CBFA1 by Smad3 decreases cbfa1 and osteocalcin expression and inhibits osteoblast differentiation. EMBO J. 20 (2001) 2254-2272
42. Jilka R.L., Weinstein R.S., Bellido T., Parfitt A.M., and Manolagas S.C. Osteoblast programmed cell death (apoptosis): modulation by growth factors and cytokines. J. Bone Miner. Res. 13 (1998) 793-802
43. Karsdal M.A., Larsen L., Engsig M.T., Lou H., Ferreras M., Lochter A., Delaisse J.M., and Foged N.T. Matrix metalloproteinase-dependent activation of latent transforming growth factor-beta controls the conversion of osteoblasts into osteocytes by blocking osteoblast apoptosis. J. Biol. Chem. 277 (2002) 44061-44067
44. Ogata Y., Niisato N., Furuyama S., Cheifetz S., Kim R.H., Sugiya H., and Sodek J. Transforming growth factor-beta 1 regulation of bone sialoprotein gene transcription: identification of a TGF-beta activation element in the rat BSP gene promoter. J. Cell Biochem. 65 (1997) 501-512
45. Kubota T., Zhang Q., Wrana J.L., Ber R., Aubin J.E., Butler W.T., and Sodek J. Multiple forms of SppI (secreted phosphoprotein, osteopontin) synthesized by normal and transformed rat bone cell populations: regulation by TGF-beta. Biochem. Biophys. Res. Commun. 162 (1989) 1453-1459
46. Lucchini M., Romeas A., Couble M.L., Bleicher F., Magloire H., and Farges J.C. TGF beta 1 signaling and stimulation of osteoadherin in human odontoblasts in vitro. Connect. Tissue Res. 43 (2002) 345-353
47. Leboy P., Grasso-Knight G., D'Angelo M., Volk S.W., Lian J.V., Drissi H., Stein G.S., and Adams S.L. Smad-Runx interactions during chondrocyte maturation. J. Bone Joint Surg. Am. 83-A Suppl. 1 (2001) S15-S22
48. Ito Y., and Miyazono K. RUNX transcription factors as key targets of TGF-beta superfamily signaling. Curr. Opin. Genet. Dev. 13 (2003) 43-47
49. Lee M.H., Kim Y.J., Kim H.J., Park H.D., Kang A.R., Kyung H.M., Sung J.H., Wozney J.M., Kim H.J., and Ryoo H.M. BMP-2-induced Runx2 expression is mediated by Dlx5, and TGF-beta 1 opposes the BMP-2-induced osteoblast differentiation by suppression of Dlx5 expression. J. Biol. Chem. 278 (2003) 34387-34394
50. Miyazono K., Maeda S., and Imamura T. Coordinate regulation of cell growth and differentiation by TGF-beta superfamily and Runx proteins. Oncogene 23 (2004) 4232-4237
51. Kang J.S., Alliston T., Delston R., and Derynck R. Repression of Runx2 function by TGF-beta through recruitment of class II histone deacetylases by Smad3. EMBO J. 24 (2005) 2543-2555